昂利康(002940.SZ)：左氧氟沙星片获得药品注册证书

Core Viewpoint - The company, Anglikang (002940.SZ), has received a drug registration certificate from the National Medical Products Administration for Levofloxacin Tablets, a third-generation fluoroquinolone antibiotic with a broad antibacterial spectrum and strong antibacterial action [1] Group 1: Product Information - Levofloxacin Tablets are the levorotatory optical isomer of Ofloxacin [1] - The drug is indicated for the treatment of adults (≥18 years) for various infections caused by specified sensitive strains, including hospital-acquired pneumonia, community-acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, complex skin and skin structure infections, uncomplicated skin and soft tissue infections, and chronic bacterial prostatitis [1]